High SHOX2 copy number variation in cancer cells leads to elevated levels of extracellular methylated SHOX2 DNA that can be used for diagnostic and prognostic purposes for patients with advanced lung cancer. This evidence concerns the gene SHOX2 and lung carcinoma.